A carregar...
Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders
INTRODUCTION: Migraine and temporomandibular disorders (TMD) are both common diseases and TMD are reported as a risk factor in migraine progression. OnabotulinumtoxinA is used in the treatment of chronic migraine (CM), and also has a potential role in TMD treatment. In this study, it is aimed to com...
Na minha lista:
| Publicado no: | Noro Psikiyatr Ars |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Noro-Psikiyatri Arsivi
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6300838/ https://ncbi.nlm.nih.gov/pubmed/30622389 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/npa.2017.19257 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|